 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/19/2024 |
$3.69 |
$3.77 |
$3.67 |
$3.72 |
217.70K | | 04/22/2024 |
$3.71 |
$3.76 |
$3.66 |
$3.67 |
345.20K | | 04/23/2024 |
$3.68 |
$3.82 |
$3.68 |
$3.73 |
180.50K | | 04/24/2024 |
$3.71 |
$3.73 |
$3.68 |
$3.70 |
196.50K | | 04/25/2024 |
$3.68 |
$3.75 |
$3.67 |
$3.69 |
174.70K |
|
|
| Atea Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections. Co's existing focus is on the development of product candidates to treat COVID-19, hepatitis C virus (HCV), dengue and respiratory syncytial virus. Co.'s product candidate for the treatment of COVID-19 is bemnifosbuvir. For the treatment of chronic HCV infection, Co. is developing a combination of bemnifosbuvir and ruzasvir, an investigational nonstructural protein 5A inhibitor. Co. is developing AT-752, an oral, purine nucleotide prodrug for the treatment of dengue. | |
|
Atea Pharmaceuticals (AVIR) has the following price history information. Looking back at AVIR historical stock prices for the last five trading days, on April 19, 2024, AVIR opened at $3.69, traded as high as $3.77 and as low as $3.67, and closed at $3.72. Trading volume was a total of 217.70K shares. On April 22, 2024, AVIR opened at $3.71, traded as high as $3.76 and as low as $3.66, and closed at $3.67. Trading volume was a total of 345.20K shares. On April 23, 2024, AVIR opened at $3.68, traded as high as $3.82 and as low as $3.68, and closed at $3.73. Trading volume was a total of 180.50K shares. On April 24, 2024, AVIR opened at $3.71, traded as high as $3.73 and as low as $3.68, and closed at $3.70. Trading volume was a total of 196.50K shares. On April 25, 2024, AVIR opened at $3.68, traded as high as $3.75 and as low as $3.67, and closed at $3.69. Trading volume was a total of 174.70K shares.
AVIR Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Atea Pharmaceuticals shares, starting with a $10,000 purchase of AVIR, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/30/2020 |
|
| End date: |
04/25/2024 |
|
| Start price/share: |
$30.34 |
|
| End price/share: |
$3.69 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-87.84% |
|
| Average Annual Total Return: |
-45.34% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,216.40 |
|
| Years: |
3.49 |
|
|
|
| Date |
Close |
| 04/19/2024 | $3.72 | | 04/22/2024 | $3.67 | | 04/23/2024 | $3.73 | | 04/24/2024 | $3.70 | | 04/25/2024 | $3.69 |
|
|
Free AVIR Email Alerts:
